Lynch & Associates’s Fidelity MSCI Health Care Index ETF FHLC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.95M | Buy |
38,211
+2,220
| +6% | +$159K | 0.52% | 51 |
|
|
2026
Q1 | $2.53M | Buy |
35,991
+425
| +1% | +$31.4K | 0.48% | 54 |
|
|
2025
Q4 | $2.64M | Buy |
35,566
+917
| +3% | +$66K | 0.5% | 51 |
|
|
2025
Q3 | $2.32M | Buy |
34,649
+943
| +3% | +$60.9K | 0.45% | 54 |
|
|
2025
Q2 | $2.16M | Buy |
33,706
+1,019
| +3% | +$64.9K | 0.43% | 55 |
|
|
2025
Q1 | $2.23M | Buy |
32,687
+44
| +0.1% | +$3.02K | 0.48% | 54 |
|
|
2024
Q4 | $2.13M | Buy |
32,643
+281
| +0.9% | +$19.5K | 0.46% | 55 |
|
|
2024
Q3 | $2.36M | Buy |
32,362
+1,897
| +6% | +$136K | 0.5% | 52 |
|
|
2024
Q2 | $2.09M | Buy |
30,465
+981
| +3% | +$66.3K | 0.47% | 55 |
|
|
2024
Q1 | $2.06M | Buy |
29,484
+2,141
| +8% | +$145K | 0.48% | 55 |
|
|
2023
Q4 | $1.77M | Buy |
27,343
+2,034
| +8% | +$124K | 0.43% | 58 |
|
|
2023
Q3 | $1.53M | Buy |
25,309
+1,229
| +5% | +$77.2K | 0.4% | 57 |
|
|
2023
Q2 | $1.52M | Buy |
24,080
+1,348
| +6% | +$84.5K | 0.39% | 56 |
|
|
2023
Q1 | $1.4M | Sell |
22,732
-647
| -3% | -$40.2K | 0.37% | 57 |
|
|
2022
Q4 | $1.5M | Sell |
23,379
-1,076
| -4% | -$67.3K | 0.39% | 57 |
|
|
2022
Q3 | $1.41M | Buy |
24,455
+1,271
| +5% | +$78.2K | 0.41% | 56 |
|
|
2022
Q2 | $1.41M | Buy |
23,184
+30
| +0.1% | +$1.86K | 0.38% | 56 |
|
|
2022
Q1 | $1.52M | Buy |
23,154
+673
| +3% | +$42.8K | 0.37% | 61 |
|
|
2021
Q4 | $1.54M | Buy |
22,481
+715
| +3% | +$47K | 0.36% | 61 |
|
|
2021
Q3 | $1.39M | Sell |
21,766
-847
| -4% | -$56K | 0.36% | 62 |
|
|
2021
Q2 | $1.44M | Sell |
22,613
-106
| -0.5% | -$6.53K | 0.37% | 62 |
|
|
2021
Q1 | $1.34M | Buy |
22,719
+1,678
| +8% | +$99.3K | 0.36% | 62 |
|
|
2020
Q4 | $1.22M | Buy |
21,041
+719
| +4% | +$39.7K | 0.33% | 61 |
|
|
2020
Q3 | $1.07M | Sell |
20,322
-26
| -0.1% | -$1.36K | 0.32% | 59 |
|
|
2020
Q2 | $1.01M | Sell |
20,348
-323
| -2% | -$15.7K | 0.33% | 58 |
|
|
2020
Q1 | $888K | Sell |
20,671
-654
| -3% | -$31K | 0.33% | 56 |
|
|
2019
Q4 | $1.06M | Buy |
21,325
+1,897
| +10% | +$88.1K | 0.3% | 57 |
|
|
2019
Q3 | $843K | Buy |
19,428
+455
| +2% | +$20.1K | 0.26% | 62 |
|
|
2019
Q2 | $854K | Buy |
18,973
+1,423
| +8% | +$62K | 0.28% | 60 |
|
|
2019
Q1 | $781K | Sell |
17,550
-340
| -2% | -$14.8K | 0.26% | 61 |
|
|
2018
Q4 | $739K | Buy |
17,890
+71
| +0.4% | +$3.12K | 0.28% | 58 |
|
|
2018
Q3 | $834K | Sell |
17,819
-163
| -0.9% | -$7.27K | 0.28% | 62 |
|
|
2018
Q2 | $743K | Buy |
17,982
+2,037
| +13% | +$83K | 0.27% | 64 |
|
|
2018
Q1 | $635K | Buy |
15,945
+1,537
| +11% | +$63.7K | 0.24% | 65 |
|
|
2017
Q4 | $576K | Buy |
14,408
+1,120
| +8% | +$44.6K | 0.22% | 62 |
|
|
2017
Q3 | $525K | Sell |
13,288
-29
| -0.2% | -$1.12K | 0.21% | 67 |
|
|
2017
Q2 | $510K | Buy |
13,317
+525
| +4% | +$19.3K | 0.2% | 73 |
|
|
2017
Q1 | $457K | Buy |
12,792
+382
| +3% | +$13.4K | 0.19% | 76 |
|
|
2016
Q4 | $408K | Buy |
12,410
+2,031
| +20% | +$67.3K | 0.17% | 78 |
|
|
2016
Q3 | $358K | Buy |
10,379
+671
| +7% | +$23.5K | 0.16% | 84 |
|
|
2016
Q2 | $328K | Buy |
9,708
+908
| +10% | +$30.2K | 0.15% | 86 |
|
|
2016
Q1 | $281K | Buy |
8,800
+317
| +4% | +$10K | 0.13% | 89 |
|
|
2015
Q4 | $293K | Buy |
8,483
+761
| +10% | +$25.7K | 0.15% | 87 |
|
|
2015
Q3 | $246K | Buy |
7,722
+333
| +5% | +$11.8K | 0.14% | 91 |
|
|
2015
Q2 | $267K | Buy |
7,389
+1,039
| +16% | +$37.3K | 0.14% | 92 |
|
|
2015
Q1 | $224K | Buy |
+6,350
| New | +$219K | 0.12% | 96 |
|
Other funds holding FHLC
TI
IRC
MAM
BFA
BIA
HCA
RT
CI
RF
FTS
Lynch & Associates's FHLC Position: Q2 2026 in Review
Lynch & Associates increased its Fidelity MSCI Health Care Index ETF (FHLC) stake by 6.2% in Q2 2026, buying an estimated $159K and bringing the position to 38,211 shares worth $2.95M. The position accounts for 0.52% of the portfolio, ranked #51.
Lynch & Associates first reported a position in FHLC in Q1 2015 and has held it in 46 quarters since. 65 funds tracked by Wall St. Rank hold FHLC as of Q2 2026.
- Lynch & Associates held 38,211 shares of Fidelity MSCI Health Care Index ETF worth $2.95M as of Q2 2026.
- Lynch & Associates bought 2,220 Fidelity MSCI Health Care Index ETF shares in Q2 2026, an estimated $159K.
- Fidelity MSCI Health Care Index ETF made up 0.52% of Lynch & Associates's portfolio in Q2 2026, its #51 holding.
- Lynch & Associates first reported a position in Fidelity MSCI Health Care Index ETF in Q1 2015 and has held it in 46 quarters since.
- 65 funds tracked by Wall St. Rank held Fidelity MSCI Health Care Index ETF as of Q2 2026.
Based on Lynch & Associates's 13F filing for Q2 2026, filed 13 Jul 2026.